Prolactinoma pathophysiology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | |||
==Overview== | |||
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. A minority of tumors are associated with multiple endocrine neoplasia type I (MEN I), Carney complex, McCune-Albright Syndrome, MEN like syndrome ( CKDN1B loss of function)<ref>http://radiopaedia.org/articles/pituitary-adenoma</ref> | |||
==Pathophysiology== | |||
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. A minority of tumors are associated with: | |||
*Multiple endocrine neoplasia type I (MEN I) | |||
*Carney complex | |||
*McCune-Albright Syndrome | |||
*MEN like syndrome ( CKDN1B loss of function)<ref>http://radiopaedia.org/articles/pituitary-adenoma</ref> | |||
== References == | == References == | ||
Revision as of 19:46, 4 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Prolactinoma pathophysiology |
|
Risk calculators and risk factors for Prolactinoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. A minority of tumors are associated with multiple endocrine neoplasia type I (MEN I), Carney complex, McCune-Albright Syndrome, MEN like syndrome ( CKDN1B loss of function)[1]
Pathophysiology
Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1), so patients with MEN 1 are at incresead risk for prolactinoma. A minority of tumors are associated with:
- Multiple endocrine neoplasia type I (MEN I)
- Carney complex
- McCune-Albright Syndrome
- MEN like syndrome ( CKDN1B loss of function)[2]